April 23, 2024

CDMO Live Europe 2026

CDMO Live Europe 2026

CDMO Live Europe 2026 

19-21 May 2026, Rotterdam

Join Europe’s Premier External Manufacturing Community at CDMO Live 2026

We are pleased to offer BioRN members 20% discount for CDMO Live Europe

CDMO Live Europe 2026 is the global meeting place for leaders in outsourced biopharma development and manufacturing.

Across three days in Rotterdam, you’ll gain actionable insights, connect with partners through curated one-to-one meetings, and experience networking like no other.

550+ external manufacturing leaders and 90+ CDMOs are gathering at CDMO Live Europe (19-21 May, Rotterdam) – the most valuable and efficient event for external manufacturing in 2026.

Our commitment is that no other external manufacturing event will give you more strategic value in 2026.

Tickets include:

  • Training Sessions – Biotech CMC Bootcamp and Strategic Partnership training sessions designed for practical application, not theory
  • PartnerMatch meetings – Pre-scheduled 1-2-1s with 90+ CDMOs matching your specific requirements. No wasted conversations.
  • 20 Outsourcing Excellence Roundtables – Peer-led discussions on supplier management, capacity planning, AI in manufacturing and Decarbonization with the PSCI
  • 40+ Manufacturing Experts Across 3 Tracks featuring analysts and executives from MSD, Roche, AstraZeneca, Daiichi Sankyo, Sandoz, J&J, Bayer and leading biotech companies
  • Unique Networking Experiences – including Cycle Tour, Rotterdam Run, and the exclusive Boat Party to create connections

Find out more: https://pharmasource.global/events/cdmolive/

 


BioRN members receive a 20 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp